MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

BHST — BioHarvest Sciences Inc. Common Stock

Nasdaq

BioHarvest Sciences Inc. Common Stock

CompareBack to Screener
$1.47
-0.02(-1.34%)
O
1.60
H
1.60
L
1.45
V
19.46K
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About BHST

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.

IndustryCommon Stock
SectorNot available
IPO DateFeb 11, 2019
Employees89
Stock ExchangeNasdaq
Ticker SymbolBHST

Key Financial Statistics

Market Cap$33.10M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$1.42 - $12.80
52-Week Avg Volume50.4K
VWAP$1.48
Transactions209
Total Recorded Bars473 days